NAUT (Nautilus Biotechnology Inc) שולי רווח תפעולי

Regarding operating margin metrics, this chart on GURU.Markets shows that -15105.70 serves as the current parameter value for Nautilus Biotechnology (NAUT). This trend reflects an eco-friendly approach to testing that reduces waste, alongside a dependency on the launch timeline of the proteomic platform while controlling R&D expenses. The development of DNA analysis through partnerships with centers accelerates the search for cancer targets, creating data synergy.
פילוחים אנליטיים של חברת Nautilus Biotechnology Inc (NAUT)

Negative dynamics in fundamental metrics highlight high risks, where the share of profit from core operations measures the efficiency of the operating cycle before taxes and interest. For Nautilus Biotechnology (NAUT), this indicator reflects the implementation stage of the Proteome Analysis Platform, as development costs exceed current revenues from pilot sales, making this chart a key tool for monitoring the company's speed in reaching operational break-even.